[B! COVID-19] Baybridgeã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯

Baybridge id:Baybridge

COVID-19ã«é–¢ã™ã‚‹Baybridgeã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯ (17)

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

${{author_name}}$
{{author_name}}{{created}}
{{ #comment }}{{ comment }}{{ /comment }}
- {{ label }}

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

å¸‚è²©ã®é¼»ã‚¹ãƒ—ãƒ¬ãƒ¼ãŒæ–°åž‹ã‚³ãƒãƒŠã®æ„ŸæŸ“çŽ‡ã‚’67ï¼…ã‚‚å‰Šæ¸›ã§ãã‚‹ã“ã¨ãŒåˆ¤æ˜Ž
ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼æ€§é¼»ç‚Žãªã©ã®æ²»ç™‚ã§ç”¨ã„ã‚‰ã‚Œã‚‹ã‚¢ã‚¼ãƒ©ã‚¹ãƒãƒ³ç‚¹é¼»è–¬(é¼»ã‚¹ãƒ—ãƒ¬ãƒ¼)ãŒã€æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡(COVID-19)ã®æ„ŸæŸ“äºˆé˜²ã«æœ‰åŠ¹ã§ã‚ã‚‹ã“ã¨ãŒã‚¢ãƒ¡ãƒªã‚«åŒ»å¸«ä¼šãŒç™ºè¡Œã™ã‚‹åŒ»å¦èªŒã®JAMA Internal Medicineã§ç™ºè¡¨ã•ã‚ŒãŸè«–æ–‡ã«ã‚ˆã‚Šæ˜Žã‚‰ã‹ã«ãªã‚Šã¾ã—ãŸã€‚ Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections: A Phase 2 Randomized Clinical Trial | Infectious Diseases | JAMA Internal Medicine | JAMA Network https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2838335 OTC nasal spray seemed to cut C
Baybridge 2025/09/04
ã•ã‚‰ã£ã¨èª¿ã¹ãŸé™ã‚Šã§ã¯ã€å›½å†…ã§ã¯ã‚¢ã‚¼ãƒ©ã‚¹ãƒãƒ³ã¯å†…æœè–¬ã¯ã‚ã£ã¦ã‚‚ç‚¹é¼»è–¬ã®å…¥æ‰‹ã¯é›£ã—ãã†ã€‚

COVID-19

ç¤¾ä¼š
ãƒªãƒ³ã‚¯
æ–°åž‹ã‚³ãƒãƒŠæ„ŸæŸ“Â 7é€±é€£ç¶šã§å¢—åŠ ã€ã„ã¾æµè¡Œã®å¤‰ç•°æ ªã€Œãƒ‹ãƒ³ãƒã‚¹ã€â€¦ç‰¹å¾´ã¯ã€Œå¼·çƒˆãªå–‰ã®ç—›ã¿ã€ã€Nã‚¹ã‚¿è§£èª¬ã€‘ | TBS NEWS DIG
å…¨å›½ã®æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®æ„ŸæŸ“è€…æ•°ãŒ7é€±é€£ç¶šã§å¢—åŠ ã—ã¦ã„ã¾ã™ã€‚ãŠç›†ä¼‘ã¿ã®ç§»å‹•ã‚„äººã”ã¿ã«ã‚‚æ³¨æ„ãŒå¿…è¦ã€‚æ„ŸæŸ“ãŒåºƒãŒã£ã¦ã„ã‚‹æ–°ã—ã„å¤‰ç•°æ ªã®ç‰¹å¾´ã‚‚ãŠä¼ãˆã—ã¾ã™ã€‚å±±å½¢ç´”èœã‚ãƒ£ã‚¹ã‚¿ãƒ¼:å…¨å›½ã§7é€±é€£ç¶šã§å¢—åŠ ã—ã¦ã„ã‚‹â€¦
Baybridge 2025/08/15
ãƒ’ãƒ‚ãƒªã‚ãƒ›ãƒƒã‚ãƒ§ãƒƒã‚ãƒ§ï¼

COVID-19

ãƒã‚¿

è¨€ã„ãŸã„ã ã‘
ãƒªãƒ³ã‚¯
ã‚³ãƒãƒŠãƒ¯ã‚¯ãƒãƒ³ã€Œäºˆé˜²åŠ¹æžœã‚ã¾ã‚Šãªã„ã€ã¯æœ¬å½“?ã€€å°¾èº«å…ˆç”Ÿã‚’ç›´æ’ƒã—ãŸ | æ¯Žæ—¥æ–°èž
è³ªå•ã«ç”ãˆã‚‹æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡å¯¾ç–åˆ†ç§‘ä¼šå…ƒä¼šé•·ã®å°¾èº«èŒ‚ã•ã‚“ï¼æ±äº¬éƒ½åƒä»£ç”°åŒºã§2025å¹´6æœˆ20æ—¥ã€å†…è—¤çµµç¾Žæ’®å½± æ”¿åºœã®æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡å¯¾ç–åˆ†ç§‘ä¼šã§ä¼šé•·ã‚’å‹™ã‚ã€æœ€ã‚‚é »ç¹ã«ãƒ‹ãƒ¥ãƒ¼ã‚¹ã«ç™»å ´ã—ãŸæ–°åž‹ã‚³ãƒãƒŠã®æœ‰è˜è€…ã§ã‚‚ã‚ã‚‹å°¾èº«èŒ‚ã•ã‚“ï¼ˆ76ï¼‰ã€‚æ°‘æ”¾ã®ãƒ†ãƒ¬ãƒ“ç•ªçµ„ã«å‡ºæ¼”ã—ãŸéš›ã®ã€ã‚³ãƒãƒŠãƒ¯ã‚¯ãƒãƒ³ã«ã¤ã„ã¦ã®ç™ºè¨€ãŒæ³¢ç´‹ã‚’å‘¼ã‚“ã§ã„ã‚‹ã€‚ ã€Œæ„ŸæŸ“ã‚’é˜²ãåŠ¹æžœã¯ã‚ã¾ã‚Šãªã„ã€ã€Œè‹¥ã„äººã¯æ„ŸæŸ“ã—ã¦ã‚‚é‡ç—‡åŒ–ã—ãªã„ã€‚æœ¬äººãŸã¡ãŒï¼ˆæŽ¥ç¨®ã‚’ï¼‰ã‚„ã‚ŠãŸã„ãªã‚‰ã©ã†ãžã¨ã€æˆ‘ã€…ã¯ä½•åº¦ã‚‚è¨€ã£ã¦ã„ã‚‹ã€ å°¾èº«ã•ã‚“ãŒæœ¬å½“ã«ã“ã‚“ãªã“ã¨ã‚’è¨€ã£ãŸã®ã ã‚ã†ã‹ã€‚çœŸæ„ãŒçŸ¥ã‚ŠãŸã„ã¨æ€ã„ã€å°¾èº«ã•ã‚“ã«å–æã‚’ç”³ã—è¾¼ã‚“ã ã¨ã“ã‚ã€Œã‚³ãƒãƒŠå¯¾ç–ã«æ·±ãé–¢ã‚ã£ãŸè€…ã¨ã—ã¦ã€å…±é€šç†è§£ã‚’å¾—ã‚‰ã‚Œã‚‹ã‚ˆã†ã«ã™ã‚‹ã®ãŒå‹™ã‚ã ã¨æ€ã£ã¦ã„ã‚‹ã€ã¨å¿œã˜ã¦ãã‚ŒãŸã€‚
Baybridge 2025/06/26
ã€Œï¼ˆé‡ç—‡åŒ–äºˆé˜²åŠ¹æžœã«æ¯”ã¹ã¦ï¼‰æ„ŸæŸ“äºˆé˜²åŠ¹æžœã¯ã‚ã¾ã‚Šãªã‹ã£ãŸã€ã¨ã„ã†ã“ã¨ãªã‚“ã ã¨æ€ã†ãŒã€æ¸¦ä¸ã«æœŸå¾…ã—ãŸã“ã¨ã¨é•ã£ãŸã“ã¨ã‚’èªã‚ã€å®Ÿç¸¾ã‚’è¦‹ã¦è¡Œã£ãŸç™ºè¨€ã§ã‚ã‚Šèª å®Ÿã ã¨æ€ã†ã€‚

COVID-19

ãƒ¯ã‚¯ãƒãƒ³
ãƒªãƒ³ã‚¯
ã€Œãƒžã‚¹ã‚¯ãªã—ä¼šé£Ÿã§æŠ—ä½“ä¸ŠãŒã£ãŸã€è¥¿æ‘åº·ç¨”ãƒ»å…ƒã‚³ãƒãƒŠæ‹…å½“ç›¸ã€æ”¿æ²»è³‡é‡‘ãƒ‘ãƒ¼ãƒ†ã‚£ãƒ¼ã§ã®ç™ºè¨€ãŒæ³¢ç´‹
è…ç¾©å‰æ”¿æ¨©ä¸‹ã§ã¯ã‚³ãƒãƒŠæ‹…å½“ç›¸ã¨ã—ã¦é€£æ—¥ãƒ¡ãƒ‡ã‚£ã‚¢ã«ç™»å ´ã—ã€ç¾åœ¨ã¯çµŒç”£ç›¸ã‚’å‹™ã‚ã‚‹è¥¿æ‘åº·ç¨”æ°ã€‚æ‰€å±žã™ã‚‹å®‰å€æ´¾ã§ã¯å¾Œç¶™ä¼šé•·å€™è£œã®ã²ã¨ã‚Šã¨ã—ã¦åå‰ãŒæŒ™ãŒã£ã¦ã„ã‚‹ã€‚ãã‚“ãªè¥¿æ‘æ°ãŒ2æœˆä¸Šæ—¬ã€è‡ªæ°‘å…šè¡†é™¢è°å“¡ã®æ”¿æ²»è³‡é‡‘ãƒ‘ãƒ¼ãƒ†ã‚£ãƒ¼ã«ã‚²ã‚¹ãƒˆã¨ã—ã¦ç™»å£‡ã—ãŸéš›ã«è©±ã—ãŸã‚³ãƒãƒŠã«é–¢ã™ã‚‹ç™ºè¨€ãŒæ³¢ç´‹ã‚’å‘¼ã‚“ã§ã„ã‚‹ã€‚ è¥¿æ‘æ°ã¯æŒ¨æ‹¶ã®å†’é ã§ã€æ˜¨å¹´9æœˆã«çµŒç”£ç›¸ã¨ã—ã¦è¡Œã£ãŸæµ·å¤–å‡ºå¼µã«ã¤ã„ã¦ã€ã“ã†ç™ºè¨€ã—ãŸã€‚ ã€Œãã®æ™‚ã®ã‚«ãƒ³ãƒœã‚¸ã‚¢ã€ã‚¿ã‚¤ã¯è¡›ç”ŸçŠ¶æ…‹ã‚‚è‰¯ããªã„ã€ãƒžã‚¹ã‚¯ã¯ã—ã¦ãªã„ã€è¿‘ã„è·é›¢ã§ä¼šè°ãŒã‚ã‚‹ã€é£Ÿäº‹ã‚‚ã‚ã‚‹ã€ã™ãæŠ±ãã¤ã‹ã‚Œã‚‹ã€‚ç”·æ€§ã§ã™ã‚ˆã€‚ãã†ã„ã†ä¸ã§ã™ãã€æ„ŸæŸ“ã‚’ã—ã¦ã—ã¾ã„ã¾ã—ã¦ã€ è¥¿æ‘æ°ã¯ã‚³ãƒãƒŠæ‹…å½“ç›¸æ™‚ä»£ã‹ã‚‰è‡ªèº«ã®æŠ—ä½“é‡ã‚’èª¿ã¹ã¦ã„ãŸã¨ã„ã†ãŒã€æ˜¨å¹´9æœˆã®æ„ŸæŸ“å¾Œã«æŠ—ä½“é‡ã‚’èª¿ã¹ãŸã¨ã“ã‚ã€æ•°å€¤ãŒä¸ŠãŒã£ã¦ã„ãŸã¨ã„ã†ã€‚ã•ã‚‰ã«æ„ŸæŸ“ã‹ã‚‰3ã‹æœˆçµŒã£ã¦å†åº¦æ¤œæŸ»ã—ãŸéš›ã«ã¯ã€æ„ŸæŸ“ç›´å¾Œã‚ˆã‚ŠæŠ—ä½“é‡ãŒä¸ŠãŒã£ã¦ã„ãŸã¨ã„ã†ã®ã ã€‚ãã‚Œã‚’è¥¿æ‘æ°ã¯ã€ã“ã†çµè«–ã¥ã‘ã¦ã„ã‚‹ã€‚ ã€Œç§
Baybridge 2023/02/28
ã€Œã‚³ãƒãƒŠã¯æœ€è¿‘5é¡žé¨’ãŽã§å•é¡Œã«ãªã£ã¦ã„ã‚‹ãŒãªã‚ã«ã€ã‹ãˆã£ã¦å…ç–«åŠ›ãŒã¤ãã€ã“ã†ã§ã™ã‹ï¼Ÿ

COVID-19

æ”¿æ²»

ãƒžã‚¹ã‚¯
ãƒªãƒ³ã‚¯
ã€Œæ–°åž‹ã‚³ãƒãƒŠã€æ”¹ã‚ã€Œã‚³ãƒãƒŠ2019ã€ã€€5é¡žç§»è¡Œã§åç§°å¤‰æ›´ - æ—¥æœ¬çµŒæ¸ˆæ–°èž
åŽšç”ŸåŠ´åƒçœã¯æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã®åç§°ã‚’ã€Œã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡2019ã€ã¨ã™ã‚‹æ¤œè¨Žã«å…¥ã£ãŸã€‚æ„ŸæŸ“ç—‡æ³•ä¸Šã€å…¥é™¢å‹§å‘Šã‚„å°±æ¥åˆ¶é™ãªã©ã®åŽ³ã—ã„æŽªç½®ãŒã¨ã‚Œã‚‹2é¡žç›¸å½“ä»¥ä¸Šã®æ‰±ã„ã‚’5æœˆã‹ã‚‰5é¡žã«å¼•ãä¸‹ã’ã‚‹ã®ã«ä¼´ã„ã€å‘¼ã³æ–¹ã‚’å¤‰ãˆã‚‹ã€‚ã€Œæ–°åž‹ã€ã¨ã„ã†è¡¨ç¾ã¯ã‚„ã‚ã€åŒ»ç™‚ãªã©ã§å¹³æ™‚ã®ä½“åˆ¶ã¸ã®ç§»è¡Œã‚’é€²ã‚ã‚‹ã€‚åŽšåŠ´çœãŒä»Šå¾Œã€åŽšç”Ÿç§‘å¦å¯©è°ä¼šï¼ˆåŽšåŠ´ç›¸ã®è«®å•æ©Ÿé–¢ï¼‰ã®æ„ŸæŸ“ç—‡éƒ¨ä¼šã«ç¤ºã—ã¦è°è«–ã™ã‚‹ã€‚ç—…åŽŸä½“åã¯ã€Œãƒ™ãƒ¼ã‚¿ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹å±ž
Baybridge 2023/02/17
æ”¹ã‚ã¦æ€ã£ãŸã‘ã©2023å¹´åž‹ãŒå‡ºã¦ãã¦ã‚‚ãŠã‹ã—ããªã„ã‚ˆãã€‚

COVID-19

åŒ»ç™‚

è¨€è‘‰
ãƒªãƒ³ã‚¯
ã‚³ãƒãƒŠ5é¡žç§»è¡Œæ™‚ã€å±‹å†…ãƒžã‚¹ã‚¯ä¸è¦ã«ã€€é€±å†…ã«é–£åƒšå”è° - æ—¥æœ¬çµŒæ¸ˆæ–°èž
ã€ã“ã®è¨˜äº‹ã®ãƒã‚¤ãƒ³ãƒˆã€‘ãƒ»ã‚³ãƒãƒŠ5é¡žç§»è¡Œå¾Œã¯å±‹å¤–ã«ç¶šãå±‹å†…ã§ã‚‚ãƒžã‚¹ã‚¯ä¸è¦ãƒ»ç™ºç†±ç—‡çŠ¶ã‚„åŸºç¤Žç–¾æ‚£ãŒã‚ã‚‹äººãªã©ã‚’é™¤ãåŽŸå‰‡é©ç”¨ã¸ãƒ»é¦–ç›¸ã€é€±å†…ã«é–£åƒšå”è°ã€‚æº€å“¡é›»è»Šã§ã®å¯¾å¿œãªã©ã¯èª¿æ•´æ”¿åºœã¯æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®æ„ŸæŸ“ç—‡æ³•ä¸Šã®ä½ç½®ä»˜ã‘ã‚’ã€Œ5é¡žã€ã¸å¤‰æ›´ã—ãŸå ´åˆã€å±‹å†…ã§ã®ãƒžã‚¹ã‚¯ç€ç”¨ã«ã¤ã„ã¦ç—‡çŠ¶ã®ã‚ã‚‹äººã‚‰ã‚’é™¤ãåŽŸå‰‡ä¸è¦ã¨ã™ã‚‹æ–¹é‡ã ã€‚å²¸ç”°æ–‡é›„é¦–ç›¸ã¯é€±å†…ã«é–¢ä¿‚é–£åƒšã¨å”è°ã—ã€æ„ŸæŸ“çŠ¶æ³ã‚’è¦‹æ¥µã‚ã¦åˆ†é¡žå¤‰æ›´ã®æ™‚æœŸã‚’åˆ¤æ–ã™ã‚‹ã€‚æ–°åž‹ã‚³
Baybridge 2023/01/18
å¤–å›½äººè¦³å…‰å®¢ã«ãƒžã‚¹ã‚¯è£…ç€ã•ã›ãŸããªã„ã¨ã„ã†æ€æƒ‘ã¯ã‚ã‚Šãã†ã€‚

COVID-19

ãƒžã‚¹ã‚¯

ç¤¾ä¼š
ãƒªãƒ³ã‚¯
ä¸å›½ã€ã‚³ãƒãƒŠæ„ŸæŸ“ã®æ»è€…ã€Œ1äººã€ã¨ç™ºè¡¨ã€€é©åˆ‡ãªæƒ…å ±å…¬é–‹ã¨ä¸»å¼µ | æ¯Žæ—¥æ–°èž
ä¸å›½ã®è¡›ç”Ÿå½“å±€ã¯5æ—¥ã€ä¸å›½ æœ¬åœŸã§4æ—¥ã«æ–°ãŸã«ç¢ºèªã—ãŸæ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã«ã‚ˆã‚‹æ»è€…ã¯1äººã ã£ãŸã¨ç™ºè¡¨ã—ãŸã€‚å…¨å›½çš„ãªå¤§æµè¡Œã®å®Ÿæ…‹ã¨ã‹ã‘é›¢ã‚ŒãŸçµ±è¨ˆãŒç¶šã„ã¦ã„ã‚‹ã‚‚ã®ã®ã€ä¸å›½æ”¿åºœã¯é©åˆ‡ã«æƒ…å ±å…¬é–‹ã—ã¦ã„ã‚‹ã¨å¼·èª¿ã€‚å„å›½ã§ç›¸æ¬¡ãå¯¾ä¸å›½ã®æ°´éš›å¯¾ç–å¼·åŒ–ã‚’ã€Œæ”¿æ²»çš„ã€ãªå‹•ãã ã¨éžé›£ã—ã¦ã„ã‚‹ã€‚ ä¸å›½ã¯å„åœ°ã§ç™ºç†±å¤–æ¥ã‚„ç«è‘¬å ´ã®æ··é›‘ã€åŒ»è–¬å“ä¸è¶³ãªã©ãŒç¶šãã€å½“å±€ã‚‚1æœˆä¸‹æ—¬ã®æ˜¥ç¯€ï¼ˆæ—§æ£æœˆï¼‰é€£ä¼‘ã«ã‹ã‘ã€ã•ã‚‰ã«æ„ŸæŸ“ãŒæ‹¡å¤§ã™ã‚‹æã‚ŒãŒã‚ã‚‹ã¨è¦æˆ’ã‚’å‘¼ã³ã‹ã‘ã¦ã„ã‚‹ã€‚â€¦
Baybridge 2023/01/06
å›½å†…å¤–ã§å ±é“ã‚’ä½¿ã„åˆ†ã‘ã‚‹ã“ã¨å¤šã„ä¸å›½ã ãŒã€ä»Šå›žã¯å›½å†…ã‚‚å›½å¤–ã‚‚ã€Œãã‚“ãªã‚ã‘ã‚ã‚‹ã‹ã„ï¼ã€ã§æ„è¦‹çµ±ä¸€ã•ã‚Œã‚‹çã—ã„ãƒ‘ã‚¿ãƒ¼ãƒ³ã€‚

ä¸å›½

COVID-19

çµ±è¨ˆ
ãƒªãƒ³ã‚¯
å²¸ç”°é¦–ç›¸ â€œæ–°åž‹ã‚³ãƒãƒŠã«æ„ŸæŸ“ç¢ºèªâ€ æ”¿åºœç™ºè¡¨ | NHK
æ”¿åºœã¯å²¸ç”°ç·ç†å¤§è‡£ãŒæ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã«æ„ŸæŸ“ã—ãŸã“ã¨ãŒç¢ºèªã•ã‚ŒãŸã¨ç™ºè¡¨ã—ã¾ã—ãŸã€‚ å†…é–£å®˜æˆ¿ã«ã‚ˆã‚Šã¾ã™ã¨ã€å²¸ç”°ç·ç†å¤§è‡£ã¯20æ—¥å¤œã«å¾®ç†±ã‚„ã›ããªã©ã®ç—‡çŠ¶ãŒå‡ºãŸãŸã‚ã€21æ—¥åˆå‰10æ™‚ã«ç·ç†å¤§è‡£å…¬é‚¸ã§PCRæ¤œæŸ»ã‚’å—ã‘ãŸã¨ã“ã‚ã€åˆå¾Œ4æ™‚ã«æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã«æ„ŸæŸ“ã—ã¦ã„ã‚‹ã“ã¨ãŒç¢ºèªã•ã‚Œã¾ã—ãŸã€‚ å²¸ç”°ç·ç†å¤§è‡£ã¯ã€å…¬é‚¸ã§ç™‚é¤Šã—ã¦ã„ã¦ã€ç¾åœ¨ã‚‚å¾®ç†±ã¨ã›ãã®ç—‡çŠ¶ãŒç¶šã„ã¦ã„ã‚‹ã¨ã„ã†ã“ã¨ã§ã™ã€‚ æ”¿åºœé–¢ä¿‚è€…ã«ã‚ˆã‚Šã¾ã™ã¨ã€æ¿ƒåŽšæŽ¥è§¦è€…ã¯è£•åå¤«äººã¨é•·ç”·ã§ç§˜æ›¸ã‚’å‹™ã‚ã‚‹ç¿”å¤ªéƒŽæ°ã®ã¿ã§ã€ç¾æ™‚ç‚¹ã§æ„ŸæŸ“çµŒè·¯ã¯åˆ†ã‹ã£ã¦ã„ãªã„ã¨ã„ã†ã“ã¨ã§ã™ã€‚ å²¸ç”°ç·ç†å¤§è‡£ã¯ä»Šæœˆ15æ—¥ã«å…¬å‹™ã‚’çµ‚ãˆãŸã‚ã¨ã€å¤ä¼‘ã¿ã«å…¥ã£ã¦ã„ã¦ã€22æ—¥ã‹ã‚‰å…¬å‹™ã«å¾©å¸°ã™ã‚‹äºˆå®šã§ã—ãŸãŒã€ä»Šæœˆ30æ—¥ã¾ã§ç™‚é¤Šã—ã€æ—©ã‘ã‚Œã°ç¿Œ31æ—¥ã‹ã‚‰å¾©å¸°ã™ã‚‹ã“ã¨ã«ãªã‚‹ã¨ã„ã†ã“ã¨ã§ã™ã€‚ ã“ã®ãŸã‚ã€ä»Šæœˆä¸‹æ—¬ã«äºˆå®šã—ã¦ã„ãŸåŒ—ã‚¢ãƒ•ãƒªã‚«ãƒ»ãƒãƒ¥ãƒ‹ã‚¸ã‚¢ã§ã®TICADï¼ã‚¢ãƒ•ãƒªã‚«é–‹ç™ºä¼šè°ã¸ã®å‡ºå¸ã‚’å–ã‚Šã‚„ã‚ã€ã‚ªãƒ³ãƒ©ã‚¤ãƒ³ã§
Baybridge 2022/08/21
ã‚†ã£ãã‚Šå®¶ã§ãƒ†ãƒ¬ãƒ“ã§ã‚‚è¦‹ã¦é™é¤Šã—ã¦ã»ã—ã„ã€‚ãã—ã¦è‡ªèº«ã®æ–½æ”¿ãŒä¸–é–“ã®æ¸©åº¦ã¨ã„ã‹ã«ã‚ºãƒ¬ã¦ã„ã‚‹ã‹æ°—ã¥ã„ã¦æˆ»ã£ã¦ãã¦ã»ã—ã„ã€‚

COVID-19

è‡ªæ°‘å…š

NHK
ãƒªãƒ³ã‚¯
ã€Œ65æ³æœªæº€ã§è»½ç—‡ã€åŸºç¤Žç–¾æ‚£ãªã—ã€ãªã‚‰å—è¨ºé¿ã‘ã¦ åŽšåŠ´ç›¸å‘¼ã³ã‹ã‘ï¼šæœæ—¥æ–°èž
æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®æ„ŸæŸ“çˆ†ç™ºã«ã‚ˆã£ã¦æ•‘æ€¥åŒ»ç™‚ã‚„ç™ºç†±å¤–æ¥ãŒé€¼è¿«ï¼ˆã²ã£ã±ãï¼‰ã—ã¦ã„ã‚‹ã“ã¨ã‚’å—ã‘ã¦ã€å¾Œè—¤èŒ‚ä¹‹åŽšç”ŸåŠ´åƒç›¸ã¯4æ—¥ã€ç—‡çŠ¶ãŒè»½ã65æ³æœªæº€ã§åŸºç¤Žç–¾æ‚£ãŒãªã‘ã‚Œã°ã€æ…Œã¦ã¦åŒ»ç™‚æ©Ÿé–¢ã‚’å—è¨ºã™ã‚‹ã“ã¨ã¯é¿ã‘ã‚‹â€¦
Baybridge 2022/08/05
è‡ªåˆ†ãŒç½¹æ‚£ã—ãŸã‚‰è»½ç—‡ã§ã‚‚çœŸã£å…ˆã«ç—…åºŠç¢ºä¿ã—ãã†ã€‚

COVID-19

è¨€ã„ãŸã„ã ã‘

åŒ»ç™‚
ãƒªãƒ³ã‚¯
å±‹å¤–ãƒžã‚¹ã‚¯ã€Œä¼šè©±ã»ã¨ã‚“ã©ãªã‘ã‚Œã°ä¸è¦ã€ã€€å°‚é–€å®¶çµ„ç¹”ãŒè¦‹è§£ | æ¯Žæ—¥æ–°èž
æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡å¯¾ç–ã‚’åŽšç”ŸåŠ´åƒçœã«åŠ©è¨€ã™ã‚‹å°‚é–€å®¶çµ„ç¹”ã€Œã‚¢ãƒ‰ãƒã‚¤ã‚¶ãƒªãƒ¼ãƒœãƒ¼ãƒ‰ï¼ˆABï¼‰ã€ã¯19æ—¥ã€ãƒžã‚¹ã‚¯ç€ç”¨ã«ã¤ã„ã¦ã€å±‹å¤–ã§å‘¨å›²ã¨ã®è·é›¢ãŒååˆ†ã«ç¢ºä¿ã§ããªã„å ´åˆã§ã‚‚ä¼šè©±ãŒã»ã¨ã‚“ã©ãªã‘ã‚Œã°ã€Œå¿…ãšã—ã‚‚å¿…è¦ãªã„ã€ã¨ã™ã‚‹è¦‹è§£ã‚’ã¾ã¨ã‚ãŸã€‚å¯¾ç–ã®ç·©å’Œã‚’æ±‚ã‚ã‚‹å£°ãŒä¸ŠãŒã‚‹ä¸ã€å¼•ãç¶šããƒžã‚¹ã‚¯ç€ç”¨ã®é‡è¦æ€§ã‚’ç¢ºèªã—ã€ä¸è¦ã¨ãªã‚‹å ´é¢ã«ã¤ã„ã¦æ”¹ã‚ã¦æ•´ç†ã—ãŸã€‚ æ”¿åºœã¯å°‚é–€å®¶ã®è¦‹è§£ã‚’å—ã‘ã€ãƒžã‚¹ã‚¯ãŒä¸è¦ãªå ´é¢ã‚„æœªå°±å¦å…ã«ã¯æŽ¨å¥¨ã—ãªã„ã“ã¨ãªã©ã‚’20æ—¥ã«ç™ºè¡¨ã™ã‚‹ã€‚
Baybridge 2022/05/20
ã‚‚ã†å°‘ã—ã—ãŸã‚‰ãƒŽãƒ¼ãƒžã‚¹ã‚¯ã®å¤–å›½äººè¦³å…‰å®¢ãŸãã•ã‚“å…¥ã£ã¦ãã¦ä¸€æ°—ã«ã†ã‚„ã‚€ã‚„ã«ãªã‚Šãã†ã€‚

ãƒžã‚¹ã‚¯

COVID-19

å¥åº·
ãƒªãƒ³ã‚¯
ã‚³ãƒãƒŠç¦ã®é«˜æ ¡ç”Ÿã®ãƒªã‚¢ãƒ« | NHKãƒ‹ãƒ¥ãƒ¼ã‚¹
ã¾ã‚‚ãªãå’æ¥ã‚’è¿Žãˆã‚‹é«˜æ ¡3å¹´ç”Ÿã€‚ é«˜æ ¡ç”Ÿæ´»ã®å¤§åŠã‚’ã‚³ãƒãƒŠã«æŒ¯ã‚Šå›žã•ã‚Œã¦ãã¾ã—ãŸã€‚ éƒ¨æ´»å‹•ã®å¤§ä¼šã‚‚ä¸æ¢ã€ä¿®å¦æ—…è¡Œã‚‚ä¸æ¢ã€‚ å¤§å¦å—é¨“ã¯ã‚ªãƒŸã‚¯ãƒãƒ³æ ªã®æ„ŸæŸ“æ‹¡å¤§ã®ä¸ã§è¡Œã‚ã‚Œã¾ã—ãŸã€‚ é™ã‚‰ã‚ŒãŸ3å¹´é–“ã®ã†ã¡ã®2å¹´â€¦
Baybridge 2022/02/17
å½¼ã‚‰ã®æ„Ÿæƒ…ã¨ã—ã¦ã¯ã”ãè‡ªç„¶ã€‚ï¼ç›®ã®å‰ã§è¨€ã‚ã‚ŒãŸã‚‰ã€ŒãŠå‰ãã‚Œã‚¹ãƒšã‚¤ãƒ³é¢¨é‚ªã‚„ãƒšã‚¹ãƒˆã®æ™‚ä»£ã§ã‚‚åŒã˜ã“ã¨è¨€ãˆã‚“ã®ã€ã¨è¿”ã™ã¨ã¯æ€ã†ï½—

ãƒ‹ãƒ¥ãƒ¼ã‚¹

COVID-19

è¨€ã„ãŸã„ã ã‘
ãƒªãƒ³ã‚¯
ç¥žå¥ˆå·çœŒã«ãŠã‘ã‚‹æ–°åž‹ã‚³ãƒãƒŠæ„ŸæŸ“è‡ªå®…ç™‚é¤Šã«ã¤ã„ã¦çµŒé¨“ã—ãŸã“ã¨å…¨éƒ¨è©±ã™ã€‚ - Everything you've ever Dreamed
ç§äº‹ã ãŒæ–°åž‹ã‚³ãƒãƒŠã«æ„ŸæŸ“ã—ã¦10æ—¥é–“è‡ªå®…ã§ç™‚é¤Šç”Ÿæ´»ã‚’é€ã£ã¦ãŠã‚Šã¾ã—ãŸã€‚æ˜Žæ—¥ã‹ã‚‰å¾©å¸°ã§ã‚ã‚‹ã€‚æ„ŸæŸ“ã—ã¦ç™ºç—‡ã—ãŸã‚‚ã®ã®ã€ä¸å¹¸ä¸ã®å¹¸ã„ã§è»½ç—‡ã§æ¸ˆã‚“ã ã€‚æ„ŸæŸ“ã—ãŸã‚¿ã‚¤ãƒŸãƒ³ã‚°ãŒãŸã¾ãŸã¾ç¥žå¥ˆå·çœŒãŒæ–¹é‡ã‚’å¤‰æ›´ã—ãŸã¨ãã¨é‡ãªã£ã¦ã€è‡ªå®…ç™‚é¤Šã‚’ã©ã†ã™ã‚Œã°ã„ã„ã®ã‹ï¼ˆå±Šã‘å‡ºç‰ï¼‰è©¦è¡ŒéŒ¯èª¤ã—ãŸã®ã§ã€ã®ã¡ã®ã¡ã®å‚è€ƒã®ãŸã‚ã«åƒ•ã®çµŒé¨“ã‚’ã“ã“ã«æ®‹ã—ã¦ãŠããŸã„ã€‚ ï¼æ—¥ç›®ï¼ˆç™ºç—‡ï¼‰ 2022å¹´1æœˆ29æ—¥åœŸæ›œæ—¥ã€‚å°±å¯å‰ã«æ¯ç£¨ãã‚’ã—ãŸéš›ã«å–‰ã«é•å’Œæ„Ÿã‚’è¦šãˆã‚‹ã€‚ãŸã¾ãŸã¾ã€æ˜¼å¯ã‚’ã—ãŸã¨ãã«ã‚¤ãƒ“ã‚ã‚’ã‹ã„ã¦ã„ãŸï¼ˆå¥¥ã•ã‚“ã«ã€Œã†ã‚‹ã›ãƒ¼ã€ã¨ã‚±ãƒªã‚’å…¥ã‚Œã‚‰ã‚ŒãŸï¼‰ã®ã§ã€ã€Œå–‰ãŒæž¯ã‚ŒãŸã®ã§ã¯ãªã„ã‹ï¼Ÿã€ã¨ãã®ã¨ãã¯æ€ã£ãŸã€‚ãã‚Œãã‚‰ã„ã€Œã‚ˆãã‚ã‚‹ã€å–‰ã®ã‚¤ã‚¬ã‚¤ã‚¬ã ã£ãŸã€‚ã„ã¤ã‚‚ãªã‚‰é¾è§’æ•£ã‚’ã‚ãƒ¡ã¦ã„ã‚‹ãƒ¬ãƒ™ãƒ«ã€‚æŒ¯ã‚Šè¿”ã£ã¦ã¿ã‚‹ã¨ã€ã“ã‚ŒãŒä¸€é€£ã®å‡ºæ¥äº‹ã®ç™ºç«¯ã ã£ãŸã€‚ã‚‚ã†ã²ã¨ã¤ã€ä»•äº‹ãŒé‡ãªã£ã¦ç–²åŠ´ãŒæºœã¾ã£ã¦ã„ãŸã®ã‚‚æ„ŸæŸ“ã®è¦å› ã§ã‚ã£ãŸã¨æ€ã†ã€‚ã¨ã«ã‹ããƒŽãƒ‰ã®ä¸èª¿ã«è¦æ³¨æ„ã ã€‚ ãƒ»ä½“èª¿ã®å¤‰åŒ–ã«
Baybridge 2022/02/09
ãƒ‘ãƒ«ã‚¹ã‚ªã‚ã‚·ãƒ¡ãƒ¼ã‚¿ãƒ¼ã¯è¿”å´ã—ãªã„å¥´ãŒç¶šå‡ºã—ã¦è‡ªæ²»ä½“ã‚‚å›°ã£ã¦ã„ã‚‹ã‚‰ã—ã„ã€‚https://www.nhk.or.jp/shutoken/newsup/20220111d.htmlï¼ç¥žå¥ˆå·çœŒHPã«ã‚ˆã‚‹ã¨ãƒ‘ãƒ«ã‚¹ã‚ªã‚ã‚·ãƒ¡ãƒ¼ã‚¿ãƒ¼ã®é€ä»˜ã¯ã€é‡ç‚¹è¦³å¯Ÿå¯¾è±¡è€…ã®ã¿ã¨ã®ã“ã¨ã€‚

ç¥žå¥ˆå·

åŒ»ç™‚

COVID-19
ãƒªãƒ³ã‚¯
ãƒ•ãƒ©ãƒ³ã‚¹ æ–°åž‹ã‚³ãƒãƒŠã§éžå¸¸äº‹æ…‹å®£è¨€ ãƒ‘ãƒªãªã©ã§å¤œé–“å¤–å‡ºç¦æ¢ã¸ | NHKãƒ‹ãƒ¥ãƒ¼ã‚¹
ãƒ•ãƒ©ãƒ³ã‚¹æ”¿åºœã¯æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®æ„ŸæŸ“ãŒå†ã³åºƒãŒã£ã¦ã„ã‚‹ã“ã¨ã‚’å—ã‘ã¦ã€ãŠã‚ˆã3ã‹æœˆã¶ã‚Šã«å…¬è¡†è¡›ç”Ÿä¸Šã®éžå¸¸äº‹æ…‹ã‚’å®£è¨€ã—ã€ä»Šæœˆ17æ—¥ã‹ã‚‰é¦–éƒ½ãƒ‘ãƒªãªã©ã§å¤œé–“ã®å¤–å‡ºãŒç¦æ¢ã•ã‚Œã‚‹ã“ã¨ã«ãªã‚Šã¾ã—ãŸã€‚ãƒ¨ãƒ¼ãƒãƒƒãƒ‘ã§ã¯æ„ŸæŸ“æ‹¡å¤§ã«æ¯æ¢ã‚ã‚’ã‹ã‘ã‚ˆã†ã¨åŽ³ã—ã„è¦åˆ¶ã‚’å°Žå…¥ã™ã‚‹å‹•ããŒç›¸æ¬¡ã„ã§ã„ã¾ã™ã€‚ ãƒ•ãƒ©ãƒ³ã‚¹ã§ã¯ä»Šæœˆ10æ—¥ã€1æ—¥ã«ç¢ºèªã•ã‚ŒãŸæ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®æ–°ãŸãªæ„ŸæŸ“è€…ãŒ2ä¸‡7000äººè¿‘ãã«ä¸Šã‚‹ãªã©ã€ã“ã¨ã—ã®æ˜¥ã‚’å¤§ããä¸Šå›žã‚‹æ°´æº–ã¨ãªã£ã¦ã„ã‚‹ã»ã‹ã€é‡ç—‡åŒ–ã—é›†ä¸æ²»ç™‚å®¤ã§æ²»ç™‚ã‚’å—ã‘ã‚‹æ‚£è€…ã‚‚å…¨å›½çš„ã«å¢—ãˆã¦ã„ã¾ã™ã€‚ ã“ã‚Œã‚’å—ã‘ã¦ãƒ•ãƒ©ãƒ³ã‚¹æ”¿åºœã¯14æ—¥ã€ç§»å‹•ã®åˆ¶é™ãªã©ã®æŽªç½®ã‚’ã¨ã‚‹ã“ã¨ãŒã§ãã‚‹ã€Œå…¬è¡†è¡›ç”Ÿä¸Šã®éžå¸¸äº‹æ…‹ã€ã‚’ãŠã‚ˆã3ã‹æœˆã¶ã‚Šã«å®£è¨€ã—ã¾ã—ãŸã€‚ å®£è¨€ã¯ä»Šæœˆ17æ—¥ã‹ã‚‰æ³•çš„ãªåŠ¹åŠ›ã‚’æŒã¤ã¨ã„ã†ã“ã¨ã§ã€ãƒžã‚¯ãƒãƒ³å¤§çµ±é ˜ã¯ãƒ†ãƒ¬ãƒ“ã®ã‚¤ãƒ³ã‚¿ãƒ“ãƒ¥ãƒ¼ã§ã€æ„ŸæŸ“ãŒã¨ãã«æ‹¡å¤§ã—ã¦ã„ã‚‹ãƒ‘ãƒªã¨ãã®å‘¨è¾ºã‚„ã€æ±éƒ¨ã®ãƒªãƒ¨ãƒ³ãªã©9ã¤ã®åœ°åŸŸã§ã€ä»Šæœˆ17æ—¥ã‹ã‚‰å°‘ãªãã¨
Baybridge 2020/10/15
ãƒ•ãƒ©ãƒ³ã‚¹ã¯çµæ§‹çœŸé¢ç›®ã«å¯¾ç–ã—ã¦ã„ã‚‹ï¼ˆå°‘ãªãã¨ã‚‚è·å ´ã§ã¯ï¼‰ã‚¤ãƒ¡ãƒ¼ã‚¸ã‚ã£ãŸã®ã§æ„å¤–ã€‚

ãƒ•ãƒ©ãƒ³ã‚¹

COVID-19
ãƒªãƒ³ã‚¯
ã€Œç§ã€åœ¨å®…å‹¤å‹™ã®æ‰èƒ½ã‚ã‚‹ã‹ã‚‚ï¼ã€ã€Œæœ¬å½“ã®æã‚ã—ã•ã¯ã“ã‚Œã‹ã‚‰ã ã‚ˆã€ã‚µã‚¤ã‚³ãƒ¼ï¼çŠ¶æ…‹ã‹ã‚‰ã ã‚“ã ã‚“ã¨å¤‰åŒ–ã—ã¦ã„ãã€Žåœ¨å®…å‹¤å‹™åã¡ã‚ƒã‚“ã€
ä¸€ç§’ @ichibyo3 ã“ã“ã¾ã§èªã‚“ã§é ‚ãã‚ã‚ŠãŒã¨ã†ã”ã–ã„ã¾ã—ãŸï¼ðŸ˜Š æœ€åˆã¯ã“ã‚“ãªã«ç¶šã‘ã‚‹äºˆå®šã§ã¯ãªã‹ã£ãŸã®ã§ã™ãŒã€50æ—¥é–“æãç¶šã‘ã‚‰ã‚ŒãŸã®ã¯ã²ã¨ãˆã«çš†æ§˜ã®å¿œæ´ã®ãŠã‹ã’ã§ã™ï¼ ã¾ãŸã¡ã‚‡ã“ã¡ã‚‡ã“ã»ã‹ã®ä½œå“ã‚’æã„ã¦ã„ãã¾ã™ã®ã§å¼•ãç¶šãã‚ˆã‚ã—ããŠé¡˜ã„ã—ã¾ã™ðŸ™Œ 2020-06-01 18:06:20
Baybridge 2020/10/13
é€”ä¸ã‹ã‚‰å‡ºç¤¾ã¸ã®ã‚«ã‚¦ãƒ³ãƒˆãƒ€ã‚¦ãƒ³æ—¥æ•°ãŒãƒãƒƒã‚ãƒªã—ãªããªã‚‹ã®ãŒã‚ã®é ƒã®ç©ºæ°—ã‚’è¡¨ã—ã¦ã„ã‚‹ã€‚

togetter

æ¼«ç”»

COVID-19
ãƒªãƒ³ã‚¯
ã€Œã¾ã•ã«æµ¦å³¶å¤ªéƒŽçŠ¶æ…‹ã€åŠå¹´é–“å¤–æ´‹èˆªæµ·ã‚’ã—ã¦ã„ãŸæ–¹ãŒæ—¥æœ¬ã§ä¸‹èˆ¹ã—ã¦é©šã„ãŸã“ã¨ã€ã‚³ãƒãƒŠã«ã‚ˆã‚‹ç¤¾ä¼šå¤‰åŒ–ã‚’æ”¹ã‚ã¦å®Ÿæ„Ÿã•ã›ã‚‰ã‚Œã‚‹
ã‚ãŸã—ã¯èˆ¹ä¹—ã‚Š@èˆ¹ @wata_huna ä¸‹èˆ¹ã—ã¾ã—ãŸã€‚ ä¸‹èˆ¹ã—ã¦é©šã„ãŸã“ã¨ã€‚ ãƒ»ã‚³ãƒ³ãƒ“ãƒ‹ã®ãƒ¬ã‚¸ã«ã€ãƒ“ãƒ‹ãƒ¼ãƒ«ã®æš–ç°¾ ãƒ»ãƒ¬ã‚¸è¢‹ãŒæœ‰æ–™ ãƒ»ç•¥å…¨å“¡ãŒãƒžã‚¹ã‚¯ã‚’ç€ç”¨ ãƒ»æ–°å¹¹ç·šã®åº§å¸ã€éš£ã«äººãŒåº§ã‚‰ãªã„ ãƒ»ã‚¢ãƒ«ã‚³ãƒ¼ãƒ«ãŒã„ãŸã‚‹æ‰€ã«è¨ç½®ã•ã‚Œã¦ã„ã‚‹ ãƒ»ãƒ†ãƒ¬ãƒ“ã®ã‚¿ãƒ¬ãƒ³ãƒˆåŒå£«ã®è·é›¢ãŒã™ã”ã„é ã„ ã“ã‚ŒãŒwithã‚³ãƒãƒŠã§ã™ã‹ 2020-09-26 15:39:58
Baybridge 2020/09/28
10ä¸‡å††çµ¦ä»˜ã¯ã‚‚ã‚‰ãˆãŸã®ã ã‚ã†ã‹ã€‚

togetter

COVID-19
ãƒªãƒ³ã‚¯
ä¸å›½ã‚¦ã‚¤ãƒ«ã‚¹ã€æ¦æ¼¢ã‚¦ã‚¤ãƒ«ã‚¹â€¦ç¦å³¶çŸ¥äº‹ãŒå‘¼ç§°ã«è‹¦è¨€ã€ŒåŽŸç™ºäº‹æ•…çµŒé¨“ã—ãŸç«‹å ´ã‹ã‚‰ã€ | æ¯Žæ—¥æ–°èž
ç¦å³¶çœŒã®å†…å €é›…é›„çŸ¥äº‹ã¯23æ—¥ã€æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã‚’å›½å†…å¤–ã®æ”¿æ²»å®¶ã‚‰ãŒã€Œä¸å›½ã‚¦ã‚¤ãƒ«ã‚¹ã€ã€Œæ¦æ¼¢ã‚¦ã‚¤ãƒ«ã‚¹ã€ãªã©ã¨å‘¼ã‚“ã ã“ã¨ã«ã¤ã„ã¦ã€ã€Œèª¤è§£ã‚„åè¦‹ã‚’ç”Ÿã‚€ã‚ˆã†ãªå¯¾å¿œã¯ã§ãã‚‹é™ã‚ŠæŽ§ãˆã‚‹ã“ã¨ãŒé‡è¦ã€ã¨è‹¦è¨€ã‚’å‘ˆã—ãŸã€‚å®šä¾‹è¨˜è€…ä¼šè¦‹ã§è³ªå•ã«ç”ãˆãŸã€‚ å†…å €çŸ¥äº‹ã¯ç‰¹å®šã®ç™ºè¨€ã®åæŒ‡ã—ã¯ã›ãšã€ã€ŒåŽŸç™ºäº‹æ•…ã‚’çµŒé¨“ã—ã€ä»ŠãªãŠé¢¨è©•ã‚’â€¦
Baybridge 2020/03/24
æ—¥æœ¬ã§ã¯ã€Œæ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚£ãƒ«ã‚¹ã¾ãŸã¯æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚£ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã€ãŒæ£å¼åç§°ã ã£ãŸã¯ãšã€‚

COVID-19

åå‰
ãƒªãƒ³ã‚¯
ã€æ¼«ç”»ã€‘ã‚³ãƒãƒŠã£ã¦å®Ÿéš›ãªã‚“ãªã®ï¼Ÿâ†’æ“¬äººåŒ–ã—ãŸæ¼«ç”»ãŒã‚ã‹ã‚Šã‚„ã™ã„ï¼ã€Œã»ã‚“ã¨åºƒã¾ã‚Œï¼ã€
ä¼Šç·’ç›´é“ @IoNaomichi å‹äººã®åä¾›ãŒã‚³ãƒãƒŠã‚’ä¸å®‰ãŒã£ã¦ãŸã®ã§ã€ä¸å®‰ãŒå’Œã‚‰ã’ã‚Œã°ã¨ãªã‚‹ã¹ãã‚ã‹ã‚Šã‚„ã™ãæ“¬äººåŒ–ã—ã¦ã¿ã¾ã—ãŸ(1/2) pic.twitter.com/dDVFGNOnN6 2020-03-08 12:25:13
Baybridge 2020/03/09
ã‚³ãƒ¼ãƒ“ãƒƒãƒ‰ã®å¾Œã¯ã€"ã˜ã‚…ã†ãã‚…ã†"ãªã®ã‹"ãƒŠã‚¤ãƒ³ãƒ†ã‚£ãƒ¼ãƒ³"ãªã®ã‹ã¯ã£ãã‚Šã—ã¦æ¬²ã—ã„ã€‚

COVID-19

æ¼«ç”»
ãƒªãƒ³ã‚¯
1